PCI Mandates Implementation of New B.Pharm Syllabus from 2026-27 Under NEP 2020

The circular, addressed to all institutions running B.Pharm courses and all examining authorities/universities approved under Sections 12(1) and 12(2) of the Pharmacy Act, 1948, emphasizes strict compliance with the newly revised syllabus framework.

The development follows the formal launch of the updated B.Pharm syllabus on April 17, 2026. Extending greetings to institutions and examining bodies, the PCI highlighted that the revision aligns with evolving educational standards under NEP 2020.

The Council noted that, with prior approval of the Central Government, it had earlier notified the Bachelor of Pharmacy (B.Pharm) Course Regulations, 2014, which remain available on its official website.

As per Regulations 6 and 8 of these rules, the course of study and subject-wise syllabus for the B.Pharm programme are to be prescribed by PCI from time to time.

It further recalled that the previous B.Pharm syllabus, framed under PCI norms, had been implemented from the academic session 2016–2017. However, in view of reforms introduced under NEP 2020, the Council has now undertaken a comprehensive revision of the syllabus. The updated syllabus has been uploaded on the PCI website (www.pci.gov.in) for reference by institutions and stakeholders.

According to the latest directive, all universities and colleges offering B.Pharm programmes have been instructed to implement the revised syllabus starting from the 2026–2027 academic session. Institutions are also required to submit compliance reports confirming the implementation of the updated curriculum.

In addition, examining authorities have been specifically requested to conduct awareness programmes to facilitate smooth and effective adoption of the revised syllabus among affiliated colleges, faculty, and students.

The circular, issued under File No. POLICY-14/7/2025-POLICY I/2394/2026 (Computer No. 386), was generated via eOffice by Pooja Kumari, IT Assistant, PCI, on April 30, 2026 at 09:36 AM.

Reinforcing the statutory nature of the directive, the PCI stated that all institutions conducting B.Pharm courses and examining authorities responsible for pharmacy examinations must strictly adhere to the provisions of the revised syllabus for the purpose of approval under Sections 12(1) and 12(2) of the Pharmacy Act, 1948.

Importantly, the Council has clarified that future extension of approval for pharmacy institutions under Section 12(1), as well as for universities under Section 12(2), will be contingent upon the proper implementation of the prescribed course of study and syllabus.